Emerging/re-emerging zoonotic diseases are a major global health problem. Linking comprehensive pathogen surveillance of arthropod/vector populations in Uganda with public health surveillance at the regional and international level will make an important contribution to human and animal health in East Africa and the One World One Health concept in general. There will be a focus on rodent-borne pathogens potentially causing disease in humans, wildlife and livestock. A more comprehensive understanding of the ecology of known and unknown rodent-borne zoonotic pathogens is essential for a risk assessment for local and global human and animal health. The establishment of emerging/re-emerging virus program on the campus of the Uganda Virus Research Institute (UVRI), Entebbe, Uganda is ongoing. Rakai is still considered as a second program site. We have procured most of the necessary equipment for the UVRI site; further equipment will be purchased when needed. Over the previous and current funding period we have established molecular and serological detection assays for several pathogens including arenaviruses, bunyaviruses, coronaviruses filoviruses, and flaviviruses. Several ongoing outbreaks, such as the current Ebola virus outbreak in the Democratic Republic of the Congo (DRC), the continuing MERS-coronavirus cases in the Middle East, and the ongoing Lassa fever outbreak in Nigeria, have delayed this project multiple times. Field work will start in the upcoming fiscal year.
| Hawman, David W; Haddock, Elaine; Meade-White, Kimberly et al. (2018) Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Res 157:18-26 |
| Zivcec, Marko; Safronetz, David; Scott, Dana P et al. (2018) Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge. PLoS Negl Trop Dis 12:e0006628 |
| Strong, James E; Feldmann, Heinz (2017) The Crux of Ebola Diagnostics. J Infect Dis 216:1340-1342 |
| Prescott, Joseph B; Marzi, Andrea; Safronetz, David et al. (2017) Immunobiology of Ebola and Lassa virus infections. Nat Rev Immunol 17:195-207 |
| Baseler, Laura; Chertow, Daniel S; Johnson, Karl M et al. (2017) The Pathogenesis of Ebola Virus Disease. Annu Rev Pathol 12:387-418 |
| Yoshida, Reiko; Muramatsu, Shino; Akita, Hiroshi et al. (2016) Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses. J Infect Dis : |
| Haddock, Elaine; Feldmann, Friederike; Feldmann, Heinz (2016) Effective Chemical Inactivation of Ebola Virus. Emerg Infect Dis 22:1292-4 |
| Hoenen, Thomas; Groseth, Allison; Rosenke, Kyle et al. (2016) Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool. Emerg Infect Dis 22:331-4 |
| Sprecher, Armand G; Caluwaerts, An; Draper, Mike et al. (2015) Personal Protective Equipment for Filovirus Epidemics: A Call for Better Evidence. J Infect Dis : |
| Ogawa, Hirohito; Miyamoto, Hiroko; Nakayama, Eri et al. (2015) Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa. J Infect Dis : |
Showing the most recent 10 out of 11 publications
